-
1
-
-
0002903141
-
Osseous tumors of intramedullary origin
-
Mirra JM, editor. Philadelphia: Lea & Febiger.
-
Mirra JM, Gold RH, Picci P. Osseous tumors of intramedullary origin. In: Mirra JM, editor. Bone tumors: Clinical radiologic, and pathologic correlations. Philadelphia: Lea & Febiger; 1989. pp. 143-438.
-
(1989)
Bone tumors: Clinical radiologic, and pathologic correlations
, pp. 143-438
-
-
Mirra, J.M.1
Gold, R.H.2
Picci, P.3
-
3
-
-
0028125701
-
Prognostic factors in osteosarcoma: A critical review
-
Davis AM, Bell RS, Goodwin PJ. Prognostic factors in osteosarcoma: A critical review. J Clin Oncol 1994; 12: 423-431.
-
(1994)
J Clin Oncol
, vol.12
, pp. 423-431
-
-
Davis, A.M.1
Bell, R.S.2
Goodwin, P.J.3
-
4
-
-
33644505791
-
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution
-
Bacci G, Longhi A, Versari M, et al. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 2006; 1: 1154-1161.
-
(2006)
Cancer
, vol.1
, pp. 1154-1161
-
-
Bacci, G.1
Longhi, A.2
Versari, M.3
-
5
-
-
0028888760
-
Clinical relevance of Ki-67 expression in bone tumors
-
Scotlandi K, Serra M, Manara MC, et al. Clinical relevance of Ki-67 expression in bone tumors. Cancer 1995; 1: 806-814.
-
(1995)
Cancer
, vol.1
, pp. 806-814
-
-
Scotlandi, K.1
Serra, M.2
Manara, M.C.3
-
6
-
-
36049027674
-
Prognostic value of P-glycoprotein in high-grade osteosarcoma
-
Serra M, Picci P, Ferrari S, Bacci G. Prognostic value of P-glycoprotein in high-grade osteosarcoma. J Clin Oncol 2007; 20: 4858-4860.
-
(2007)
J Clin Oncol
, vol.20
, pp. 4858-4860
-
-
Serra, M.1
Picci, P.2
Ferrari, S.3
Bacci, G.4
-
7
-
-
18844467502
-
Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis
-
Kaya M, Wada T, Akatsuka T, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 2000; 6: 572-577.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 572-577
-
-
Kaya, M.1
Wada, T.2
Akatsuka, T.3
-
8
-
-
4344583344
-
What makes vessels grow with exercise training?
-
Prior BM, Yang HT, Terjung RL. What makes vessels grow with exercise training? J App Physiol 2004; 97: 1119-1128.
-
(2004)
J App Physiol
, vol.97
, pp. 1119-1128
-
-
Prior, B.M.1
Yang, H.T.2
Terjung, R.L.3
-
9
-
-
72849123834
-
Vascular endothelial growth factor in children with neuroblastoma: A retrospective analysis
-
Jakovljević G, Culić S, Stepan J, et al. Vascular endothelial growth factor in children with neuroblastoma: A retrospective analysis. J Exp Clin Cancer Res 2009; 6: 143.
-
(2009)
J Exp Clin Cancer Res
, vol.6
, pp. 143
-
-
Jakovljević, G.1
Culić, S.2
Stepan, J.3
-
10
-
-
33749187067
-
The prognostic significance of angiogenesis and the effect of vascular endothelial growth factor on angiogenic process in Wilms' tumour
-
Ozluk Y, Kilicaslan I, Gulluoglu MG, et al. The prognostic significance of angiogenesis and the effect of vascular endothelial growth factor on angiogenic process in Wilms' tumour. Pathology 2006; 38: 408-414.
-
(2006)
Pathology
, vol.38
, pp. 408-414
-
-
Ozluk, Y.1
Kilicaslan, I.2
Gulluoglu, M.G.3
-
11
-
-
14644440555
-
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis
-
Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 10: 1011-1027.
-
(2005)
J Clin Oncol
, vol.10
, pp. 1011-1027
-
-
Hicklin, D.J.1
Ellis, L.M.2
-
12
-
-
0037163646
-
The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy
-
Manders P, Beex LV, Tjan-Heijnen VC, et al. The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy. Br J Cancer 2002; 87: 772-778.
-
(2002)
Br J Cancer
, vol.87
, pp. 772-778
-
-
Manders, P.1
Beex, L.V.2
Tjan-Heijnen, V.C.3
-
13
-
-
0034075041
-
Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients
-
Lee JC, Chow NH, Wang ST, et al. Prognostic value of vascular endothelial growth factor expression in colorectal cancer patients. Eur J Cancer 2000; 36: 748-753.
-
(2000)
Eur J Cancer
, vol.36
, pp. 748-753
-
-
Lee, J.C.1
Chow, N.H.2
Wang, S.T.3
-
14
-
-
0030996171
-
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study
-
Fontanini G, Lucchi M, Vignati S, et al. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: A prospective study. J Natl Cancer Inst 1997; 89: 881-886.
-
(1997)
J Natl Cancer Inst
, vol.89
, pp. 881-886
-
-
Fontanini, G.1
Lucchi, M.2
Vignati, S.3
-
15
-
-
37549040613
-
Paclitaxel pus bevacizumab versus paclitaxel alone for metastatic breast cancer
-
Miller K, Wang M, Gralow J, et al. Paclitaxel pus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med 2007; 357: 2666-2676.
-
(2007)
N Engl J Med
, vol.357
, pp. 2666-2676
-
-
Miller, K.1
Wang, M.2
Gralow, J.3
-
16
-
-
55249100794
-
Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma
-
Escudier B, Cosaert J, Pisa P. Bevacizumab: direct anti-VEGF therapy in renal cell carcinoma. Expert Rev Anticancer Ther 2008; 8: 1545-1557.
-
(2008)
Expert Rev Anticancer Ther
, vol.8
, pp. 1545-1557
-
-
Escudier, B.1
Cosaert, J.2
Pisa, P.3
-
17
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
-
(2004)
N Engl J Med
, vol.350
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
-
18
-
-
77958465052
-
Bevacizumab: Current updates in treatment
-
Van Meter ME, Kim ES. Bevacizumab: Current updates in treatment. Curr Opin Oncol 2010; 22: 586-591.
-
(2010)
Curr Opin Oncol
, vol.22
, pp. 586-591
-
-
Van Meter, M.E.1
Kim, E.S.2
-
20
-
-
79960328502
-
Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma
-
Epub ahead of print].
-
Lin F, Zheng SE, Shen Z, et al., Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma. Med Oncol 2010 [Epub ahead of print].
-
(2010)
Med Oncol
-
-
Lin, F.1
Zheng, S.E.2
Shen, Z.3
-
21
-
-
33645758312
-
Outcome of patients with osteosarcoma over 40 years of age: Is angiogenesis a marker of survival?
-
Ek ET, Ojaimi J, Kitagawa Y, et al. Outcome of patients with osteosarcoma over 40 years of age: Is angiogenesis a marker of survival? Int Semin Surg Oncol 2006; 21: 7.
-
(2006)
Int Semin Surg Oncol
, vol.21
, pp. 7
-
-
Ek, E.T.1
Ojaimi, J.2
Kitagawa, Y.3
-
22
-
-
0034923620
-
Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma
-
Mantadakis E, Kim G, Reisch J. Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma. J Pediatr Hematol Oncol 2001; 23: 286-289.
-
(2001)
J Pediatr Hematol Oncol
, vol.23
, pp. 286-289
-
-
Mantadakis, E.1
Kim, G.2
Reisch, J.3
-
23
-
-
11144245499
-
Prognostic relevance of increased angiogenesis in osteosarcoma
-
Kreuter M, Bieker R, Bielack SS, et al. Prognostic relevance of increased angiogenesis in osteosarcoma. Clin Cancer Res 2004; 10: 8531-8537.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 8531-8537
-
-
Kreuter, M.1
Bieker, R.2
Bielack, S.S.3
-
24
-
-
0020517706
-
Morphological grades of regression in osteosarcoma after polychemotherapy-Study COSS 80
-
Salzer-Kuntschik M, Delling G, Beron G, Sigmund R. Morphological grades of regression in osteosarcoma after polychemotherapy-Study COSS 80. J Cancer Res Clin Oncol 1983; 106. (Suppl:21-4).
-
(1983)
J Cancer Res Clin Oncol
, vol.106
, Issue.SUPPL. 21-4
-
-
Salzer-Kuntschik, M.1
Delling, G.2
Beron, G.3
Sigmund, R.4
-
25
-
-
53949112697
-
Prognostic significance of alpha V integrin and VEGF in osteosarcoma after chemotherapy
-
Huang Y, Lin Z, Zhuang J. Prognostic significance of alpha V integrin and VEGF in osteosarcoma after chemotherapy. Onkologie 2008; 31: 535-540.
-
(2008)
Onkologie
, vol.31
, pp. 535-540
-
-
Huang, Y.1
Lin, Z.2
Zhuang, J.3
-
26
-
-
77949419636
-
Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: An immunohistochemical analysis
-
Rossi B, Schinzari G, Maccauro G. Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: An immunohistochemical analysis. BMC Musculoskelet Disord 2010; 16: 34.
-
(2010)
BMC Musculoskelet Disord
, vol.16
, pp. 34
-
-
Rossi, B.1
Schinzari, G.2
Maccauro, G.3
-
27
-
-
0033166894
-
Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma
-
Lee YH, Tokunaga T, Oshika Y, et al. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 1999; 35: 1089-1093.
-
(1999)
Eur J Cancer
, vol.35
, pp. 1089-1093
-
-
Lee, Y.H.1
Tokunaga, T.2
Oshika, Y.3
-
28
-
-
33646125873
-
CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: Analysis within a group of patients, all of whom developed lung metastasis
-
Oda Y, Yamamoto H, Tamiya S. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: Analysis within a group of patients, all of whom developed lung metastasis. Mod Pathol 2006; 19: 738-745.
-
(2006)
Mod Pathol
, vol.19
, pp. 738-745
-
-
Oda, Y.1
Yamamoto, H.2
Tamiya, S.3
-
29
-
-
5044223651
-
Tumor angiogenesis and outcome in osteosarcoma
-
Mikulić D, Ilić I, Cepulić M. et al. Tumor angiogenesis and outcome in osteosarcoma. Pediatr Hematol Oncol 2004; 21: 611-619.
-
(2004)
Pediatr Hematol Oncol
, vol.21
, pp. 611-619
-
-
Mikulić, D.1
Ilić, I.2
Cepulić, M.3
|